PMID- 15929080 OWN - NLM STAT- MEDLINE DCOM- 20051115 LR - 20160303 IS - 0020-7136 (Print) IS - 0020-7136 (Linking) VI - 117 IP - 4 DP - 2005 Nov 20 TI - Interaction of host and viral risk factors for development of cervical carcinoma in situ. PG - 690-2 AB - Infection by oncogenic human papillomavirus (HPV) is a necessary but not sufficient cause of cervical carcinoma. Several host genetic and viral factors have been reported to increase the risk of carcinoma development given an HPV infection. In our study, we have analysed the contribution of HPV 16 E6 sequence subtype and allelic variation at human leukocyte antigen (HLA) class II loci to the risk of developing cervical carcinoma in situ. Non-European-like HPV 16 E6 sequence subtypes were not found to be associated with an increased risk of cervical carcinoma, as compared to European-like variants. However, an association was found between the HPV 16 E6 L83V variant and the DR*04-DQ*03 haplotype. This association has been observed in several independent studies and shows that both the host HLA class II genotype and viral subtype will affect the risk of an infection progressing into cervical carcinoma. CI - Copyright 2005 Wiley-Liss, Inc. FAU - Beskow, Anna H AU - Beskow AH AD - Department of Genetics and Pathology, Rudbeck Laboratory, University of Uppsala, Sweden. FAU - Engelmark, Malin T AU - Engelmark MT FAU - Magnusson, Jessica J AU - Magnusson JJ FAU - Gyllensten, Ulf B AU - Gyllensten UB LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Int J Cancer JT - International journal of cancer JID - 0042124 RN - 0 (DNA Primers) SB - IM MH - Base Sequence MH - Carcinoma in Situ/*virology MH - Case-Control Studies MH - DNA Primers MH - Female MH - Humans MH - Papillomaviridae/*isolation & purification MH - Retrospective Studies MH - Risk Factors MH - Uterine Cervical Neoplasms/*virology EDAT- 2005/06/02 09:00 MHDA- 2005/11/16 09:00 CRDT- 2005/06/02 09:00 PHST- 2005/06/02 09:00 [pubmed] PHST- 2005/11/16 09:00 [medline] PHST- 2005/06/02 09:00 [entrez] AID - 10.1002/ijc.21212 [doi] PST - ppublish SO - Int J Cancer. 2005 Nov 20;117(4):690-2. doi: 10.1002/ijc.21212.